bringing
microbiomics
to the clinics
bringing
microbiomics
to the clinics
We improve the clinical management of chronic diseases thanks to reliable, clinical-grade gut microbiome analysis.
Microbiome science with clinical value
Mounting evidence points to changes in the composition and functionality of the gut microbiota in a growing list of medical conditions such as liver and bowel diseases, diabetes, obesity, mental disorders and cancer.
Microbiome science
with clinical value
Mounting evidence points to changes in the composition and functionality of the gut microbiota in a growing list of medical conditions such as liver and bowel diseases, diabetes, obesity, mental disorders and cancer.
liver diseases
bowel diseases
diabetes
mental disorders
cancer
This offers opportunities to use microbiome-based biomarkers in clinical management.
However, clinicians are still in need of reliable solutions to assess the microbiome of their patients for disease prevention, monitoring and prognosis.
This offers opportunities to use microbiome-based biomarkers in clinical management.
However, clinicians are still in need of reliable solutions to assess the microbiome of their patients for disease prevention, monitoring and prognosis.
Robust, reliable and precise microbiome analysis
We leverage standardized analytical procedures, high-quality quantitative metagenomics and proprietary AI-based algorithms to bring robust and reproducible microbiome analysis to medical laboratories. Our microbiome analysis software is a CE-marked medical device for in vitro diagnostic.
By providing precise metrics and reference values to medical labs, GMT Science allows physicians to take the patient’s microbiome into account in their clinical practice.
We leverage standardized analytical procedures, high-quality quantitative metagenomics and proprietary AI-based algorithms to bring robust and reproducible microbiome analysis to medical laboratories. Our microbiome analysis software is a CE-marked medical device for in vitro diagnostic.
By providing precise metrics and reference values to medical labs, GMT Science allows physicians to take the patient’s microbiome into account in their clinical practice.
Etienne Formstecher
Former
CEO – Hybrigenics Services
Omics-based therapeutic target identification and drug discovery
CEO
Etienne Formstecher, PhD
Raynald de Lahondès
Former
President – Sibio
Information systems & software development for the biotech industry
CTO
Raynald de Lahondès, PhD
Benjamin Duplan
Former
Business Development – Greapz 3D
Recruitment consultant – Robert Walters
Financial auditor – EY
CFO
Benjamin Duplan
Thomas Joder
Sales engineer – Cegid
Business developer – H5 Audit
Life science expert consultant – Umanis CGI
CBO
Thomas Joder
Joël Doré
Scientific Director – MetaGenoPolis, INRAE
Host-microbiota symbiosis in health and disease
Microbiome Science Adviser
Joël Doré, PhD
Pierre Déchelotte
Professor of Nutrition – CHU Rouen
Nutrition, Inflammation and Microbiota-Gut-Brain axis – INSERM
Medical Adviser
Pierre Dechelotte, MD, PhD
Edi Prifti
Senior Researcher – IRD
Associate Researcher – Nutriomics, INSERM / Sorbonne University
AI, data science and microbiome modelling applied to complex diseases
Data science & biostatistics Adviser
Edi Prifti, PhD
Michel Laborde
Former
CIO – Enterome
CIO – Integrated BioBank of Luxembourg
CEO – ORIAM Medical softwares
Medical IT Adviser
Michel Laborde, MD
Vadim Puller
Former
Bioinformatician – omicX
AI systems assembling bioinformatics pipelines
Bioinformatics
Vadim Puller, PhD
Thomas Moncion
Former
Bioinformatician – Pathoquest
Metagenomics-based microbiology testing
Head of bioinformatics platform – Hybrigenics Services
Software Development & Bioinformatics
Thomas Moncion, PhD
Florian Plaza Oñate
Microbiome data scientist – MetaGenoPolis, INRAE
Bioinformatics
Florian Plaza Oñate, PhD
Baptiste Hennecart
Rouen MSc Bioinformatics Data Science
Bioinformatics
Baptiste Hennecart, Apprentice MSc
Fay Betsou
Director, Biological Resource Center, Institut Pasteur
Fay Betsou, PhD
Francisco Guarner
Digestive System Research Unit, University Hospital Vall d’Hebron
Consultant of Gastroenterology, Teknon Medical Centre, Barcelona
Francisco Guarner, MD, PhD
OFFICES
GMT Science – Paris Biotech Santé
24, rue du Faubourg Saint-Jacques
75014 PARIS
LAB
75 route de Lyons-la-Forêt
76000 Rouen
